Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Germany Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20031
20041
20063
20071
20091
20101
20112
20122
20131
20142
20151
20171
20184
20193
20204
20212
20225
20233
20244
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting13
Active, not recruiting6
Terminated6
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group11
AstraZeneca4
AbbVie3
Eli Lilly and Company3
North Eastern German Society of Gynaecological Oncology3
Amgen2
Merck Sharp & Dohme LLC2
pharmaand GmbH2
Aesculap AG1
Charite University, Berlin, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms54
Ovarian Neoplasms43
Carcinoma, Ovarian Epithelial18
Peritoneal Neoplasms11
Endometrial Neoplasms7
Neoplasms5
Uterine Cervical Neoplasms4
Recurrence3
Adenocarcinoma, Clear Cell2
Breast Neoplasms2

Trials

Showing 76 to 54 of 54. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.